NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Grant Avenue Capital, LLC, www.GrantAveCap.com, a New York-based healthcare-focused private equity firm, announ

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Roughly 133 million Americans live with chronic health conditions, struggling in varying degrees with everyday life and yearning for support and community. This is why Healthline Media, the

SAN CARLOS, Calif., Sept. 4, 2019 /PRNewswire/ -- Natera, Inc. (NAS

REDWOOD CITY, Calif., Sept. 4, 2019 /PRNewswire/ -- Bolt Biotherapeutics, Inc., a private biotechnology company focused on unleashing the power of the immune system to treat cancer, today announced that it has appointed Randall Schatzman, Ph.D. to the position of chief executive officer and as a member of Bolt's board of directors. Dr. Scha

WASHINGTON, Sept. 4, 2019 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to announce that Giovanni Caforio, M.D., chairman and CEO of Bristol-Myers Squibb has assumed the role of chairman of the PhRMA board of directors.

ST. LOUIS, Sept. 4, 2019 /PRNewswire/ -- Bayer has awarded

MALVERN, Pa., Sept. 4, 2019 /PRNewswire/ -- On September 3, YPrime, a global leader of cloud-based eClinical solutions debuted the new home for its headquarters. Based in Malvern, PA, this state-of-the-art office facility houses product development, project delivery, support services, commercial and corp

BETHESDA, Md., Sept. 4, 2019 /PRNewswire/ -- The Foundation for the National Institutes of Health (FNIH) has selected the finalists of the 2nd annual Trailblazer Prize for Clinician-Scientists (Trailblazer Prize): Ami S. Bhatt, M.D., Ph.D., Stanford University, James Kochen

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office in Cary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two existing U

FLAGSTAFF, Ariz., Sept. 4, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be presenting at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright in New York City.